Evidence map›Paper›PMID 32368146›Full record

ArticleCancer management and research2020

Low Albumin to Fibrinogen Ratio Predicts Poor Overall Survival in Esophageal Small Cell Carcinoma Patients: A Retrospective Study.

Yan Wang, Jialong Li, Shuai Chang, Kun Zhou, Guowei Che

Abstract read
In one paragraph

Article in Cancer management and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. FAR Ratio as Prognostic Biomarker in AMI.SN comprehensive clinical medicine · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan Wang *Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.ORCID 0000-0001-8622-3480
Jialong Li *Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Shuai ChangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Kun ZhouDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Guowei CheDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.ORCID 0000-0003-2187-6346

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore the prognostic value of albumin to fibrinogen ratio (AFR) in patients with esophageal small cell carcinoma (ESCC). PATIENTS AND

methodsPatients diagnosed with ESCC in West China Hospital from June 1, 2010, to July 31, 2019, were retrospectively reviewed. The AFR was defined as the ratio between the serum albumin level and fibrinogen level. The receiver operating characteristic curves were conducted to determine optimal cut-off values for survival prediction. Univariate and multivariate cox regression analyses were performed to clarify independent prognostic risk factors.

resultsA total of 88 ESCC patients were enrolled in our study with the median follow-up time of 6 months (range 1-91 months). In the univariate analysis, the node metastasis, extraesophageal metastasis status, tumor-node-metastasis (TNM) stage and AFR were found to be potentially related with overall survival (OS) of ESCC patients. After the multivariate analysis, AFR [hazard ratio (HR)=3.487, 95% confidence interval (CI): 1.179-10.312;

conclusionThe current study reported that AFR could serve as a novel prognostic indicator in ESCC and patients with AFR≤12.36 were more likely to have poor prognosis.

Indexed as

albumin to fibrinogen ratioesophageal small cell carcinomaoverall survival

Identifiers

PMID32368146
PMCPMC7183346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.